Supplier
Access Drugs, LLC
Access Drugs, LLC was paid $15K by Medicaid between Sep 2021 and Oct 2021, across 1 billing code. Its largest line is M0243, Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring — 100% of everything it billed.
33Billing provider infoACCESS DRUGS, LLC
CHATTANOOGA, TN 37415
CHATTANOOGA, TN 37415
33aNPI1679546782assigned 02/09/2006
33bProvider typeLong Term Care Pharmacy
28Total paid$15K
24GClaims41
24DCodes billed1
24AFirst – last monthSep 2021 – Oct 2021
Compared with peers
Next to other Long Term Care Pharmacy providers in Tennessee
Rank by total paid#3 of 8
Median peer was paid$19.36
This provider vs. median798×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 41 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 100% | 41 | 41 | $15K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTANDEFER, RETA (CO-OWNER)